C12N 2501/16
Activin
Official title: Activin; Inhibin; Mullerian inhibiting substance
C12N2501/16 (Activin) appears on 506 US grants and 1,074 published applications in this corpus.
Search patents in C12N- Granted patents
- 506
- Published applications
- 1,074
- Assignees
- 381
- Inventors
- 1,619
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 4 |
| 2004 | 0 | 6 |
| 2005 | 1 | 6 |
| 2006 | 1 | 7 |
| 2007 | 2 | 12 |
| 2008 | 2 | 8 |
| 2009 | 4 | 28 |
| 2010 | 7 | 39 |
| 2011 | 9 | 25 |
| 2012 | 13 | 36 |
| 2013 | 15 | 43 |
| 2014 | 20 | 45 |
| 2015 | 34 | 52 |
| 2016 | 29 | 75 |
| 2017 | 41 | 61 |
| 2018 | 45 | 60 |
| 2019 | 41 | 72 |
| 2020 | 34 | 65 |
| 2021 | 33 | 62 |
| 2022 | 29 | 82 |
| 2023 | 25 | 77 |
| 2024 | 48 | 77 |
| 2025 | 40 | 80 |
| 2026 | 28 | 50 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Haematopoietic stem/progenitor cells29 Sep 2026US 12,747,424 B2Murdoch Childrens Research Institute
- Generation of uniform hepatocytes from human embryonic stem cells by inhibiting TGF-beta and methods of maintaining hepatic cultures15 Sep 2026US 12,734,197 B2Wisconsin Alumni Research Foundation
- Methods and compositions for generating oligodendrocyte progenitor cells8 Sep 2026US 12,729,368 B2Trailhead Biosystems Inc.
- Methods for the production of cardiac fibroblasts25 Aug 2026US 12,714,728 B2FUJIFILM Cellular Dynamics, Inc.
- Human polarised three-dimensional cellular aggregates18 Aug 2026US 12,709,734 B2Cambridge Enterprise Limited
- Micropattern-assisted generation of tissue8 Oct 2026US 2026/0308533 A1
- Cryopreserved endocrine cells that express chromogranin a1 Oct 2026US 2026/0294981 A1ViaCyte, Inc.
- SIRPalpha Knockout iPSC-derived and CAR-comprising Macrophages with Enhanced Anti-tumor Activity24 Sep 2026US 2026/0284104 A1Wisconsin Alumni Research Foundation
- Differentiation of ipscs in bioreactors24 Sep 2026US 2026/0286309 A1Repairon GmbH
- Compositions and methods for differentiating rpe cells17 Sep 2026US 2026/0275281 A1Stemcell Technologies Canada Inc.
Most cited
By later US patents
- Definitive endoderm221US 7,510,876 B2Cythera, Inc. · 2009
- Endoderm cells from human embryonic stem cells169US 7,326,572 B2Geron Corporation · 2008
- Methods of producing pancreatic hormones165US 7,534,608 B2Cythera, Inc. · 2009
- Methods for identifying factors for differentiating definitive endoderm163US 7,541,185 B2Cythera, Inc. · 2009
- Islet cells from human embryonic stem cells152US 7,033,831 B2Geron Corporation · 2006